financetom
Business
financetom
/
Business
/
Nvni Files Appeal Against Nasdaq Delisting
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nvni Files Appeal Against Nasdaq Delisting
Nov 15, 2024 2:23 PM

04:56 PM EST, 11/15/2024 (MT Newswires) -- Nvni Group ( NVNI ) said Friday that it filed an appeal of a delisting determination to the Nasdaq Hearings Panel.

The appeal stays the suspension of Nvni's ( NVNI ) securities from the exchange for 15 days, according to the company.

Nvni ( NVNI ) said it plans to file for an additional stay covering the appeal process and any extension granted by the panel.

The company said it received a staff determination letter from Nasdaq's listing qualifications department on Tuesday for failing to file its annual report for the year ended Dec. 31, 2023.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CVS Health Unusual Options Activity For June 05
CVS Health Unusual Options Activity For June 05
Jun 5, 2024
High-rolling investors have positioned themselves bullish on CVS Health ( CVS ) , and it's important for retail traders to take note. This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in CVS often signals that someone has privileged information. Today, Benzinga's...
ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment
ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment
Jun 5, 2024
11:26 AM EDT, 06/05/2024 (MT Newswires) -- ArriVent BioPharma ( AVBP ) said Wednesday that it signed a collaboration agreement with Alphamab Oncology's Jiangsu Alphamab Biopharmaceuticals unit to discover, develop, and commercialize antibody drug conjugates for cancer treatment. The collaboration will leverage Alphamab's linker-payload platform and glycan-conjugation technology to identify ADCs, the company said, adding that ArriVent will have exclusive...
Boeing's Starliner Lifts Off on First Crewed Mission
Boeing's Starliner Lifts Off on First Crewed Mission
Jun 5, 2024
10:59 AM EDT, 06/05/2024 (MT Newswires) -- Boeing's ( BA ) Starliner launched at 10:52 a.m. ET Wednesday with two NASA astronauts aboard, headed to the International Space Station. Price: 188.07, Change: -0.55, Percent Change: -0.29 ...
Why Fortuna Silver Mines (FSM) Stock Is Diving
Why Fortuna Silver Mines (FSM) Stock Is Diving
Jun 5, 2024
Fortuna Silver Mines Inc ( FSM ) shares are trading lower by 15% to $5.02 during Wednesday’s session after the company announced an offering of convertible senior notes worth $150 million, due in 2029, with an option for initial purchasers to buy an additional $22.5 million in notes. The proceeds will be used to repay bank debt, fund working capital,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved